Molecular mechanisms in therapy of acid-related diseases

Cellular and Molecular Life Sciences

Volumn 65, Issue 2, 2008, Pages 264-281

  Shin, J M ^a,b   Vagin, O ^a,b   Munson, K ^a,b   Kidd, M ^c   Modlin, I M ^c   Sachs, G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gastric acid secretion; Gastroesophageal reflux disease; H,K ATPase; Peptic ulcer; Pharmacology; Proton pump inhibitors

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANTACID AGENT; ATROPINE; BELLADONNA ALKALOID; BENATOPRAZOLE; BURIMAMIDE; CIMETIDINE; FAMOTIDINE; GASTRIN ANTAGONIST; GLUTATHIONE; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; LANSOPRAZOLE; METIAMIDE; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC M3 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR BLOCKING AGENT; NIZATIDINE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PICOPRAZOLE; POTASSIUM COMPETITIVE ACID BLOCKER; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; STOMACH SECRETION INHIBITOR; TIMOPRAZOLE; UNINDEXED DRUG;

BLURRED VISION; DRUG BINDING; DRUG HALF LIFE; DRUG MECHANISM; DRUG TARGETING; DYSPEPSIA; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MICTURITION DISORDER; MOLECULAR DYNAMICS; MYDRIASIS; NONHUMAN; PEPTIC ULCER; PROTEIN ANALYSIS; PROTEIN STRUCTURE; REVIEW; STOMACH ACID SECRETION; STOMACH PARIETAL CELL; STRUCTURE ACTIVITY RELATION; UNSPECIFIED SIDE EFFECT; VAGOTOMY; XEROSTOMIA;

DYSPEPSIA; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; H(+)-K(+)-EXCHANGING ATPASE; HUMANS; PEPTIC ULCER; PROTON PUMP INHIBITORS;

EID: 38549160698     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-7249-x     Document Type: Review

References (89)

1. Black, J. W., Duncan, W. A. M., Durant, C. J., Ganellin, C. R. and Parsons, M. E. (1972) Definition and antagonism of histamine H2 receptors. Nature 236, 385-390.
2. Hirschowitz, B. I. and Sachs, G. (1969) Atropine inhibition of insulin-, histamine-, and pentagastrin-stimulated gastric electrolyte and pepsin secretion in the dog. Gastroenterology 56, 693-702.
3. Sachs, G., Chang, H. H., Rabon, E., Schackman, R., Lewin, M. and Saccomani, G. (1976) A nonelectrogenic H+ pump in plasma membranes of hog stomach. J. Biol. Chem. 251, 7690-7698.
4. Chang, H., Saccomani, G., Rabon, E., Schackmann, R. and Sachs, G. (1977) Proton transport by gastric membrane vesicles. Biochim. Biophys. Acta 464, 313-327.
5. Forte, J. G., Ganser, A., Beesley, R. and Forte, T. M. (1975) Unique enzymes of purified microsomes from pig fundic mucosa: K+-stimulated adenosine triphosphatase and K+-stimulated pNPPase. Gastroenterology 69, 175-189.
6. Ganser, A. L. and Forte, J. G. (1973) K + -stimulated ATPase in purified microsomes of bullfrog oxyntic cells. Biochim. Biophys. Acta 307, 169-180.
7. Saccomani, G., Shah, G., Spenney, J. G. and Sachs, G. (1975) Characterization of gastric mucosal membranes. VIII. The localization of peptides by iodination and phosphorylation. J. Biol. Chem. 250, 4802-4809.
8. Modlin, I. M. (1990). From Prout to the proton pump - a history of the science of gastric acid secretion and the surgery of peptic ulcer. Surg. Gynecol. Obstet. 170, 81-96.
9. Wilkes, J. M., Kajimura, M., Scott, D. R., Hersey, S. J. and Sachs, G. (1991) Muscarinic responses of gastric parietal cells. J. Membr. Biol. 122, 97-110.
10. Carmine, A. A. and Brogden, R. N. (1985) Pirenzepine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases. Drugs 30, 85-126.
11. McCarthy, D. M., Olinger, E. J., May, R. J., Long, B. W. and Gardner, J. D. (1977) H2-Histamine receptor blocking agents in the Zollinger-Ellison syndrome: experience in seven cases and implications for long-term therapy. Ann. Intern. Med. 87, 668-675.
12. Wilder-Smith, C. H. and Merki, H. S. (1992) Tolerance during dosing with H2-receptor antagonists: an overview. Scand. J. Gastroenterol. Suppl. 193, 14-19.
13. Modlin, I. M., Sachs, G., Wright, N. and Kidd, M. (2005). Edkins and a century of acid suppression. Digestion 72:129-145.
14. Calam, J., Gibbons A., Healey, Z. V., Bliss, P., Arebi, N. (1997) How does Helicobacter pylori cause mucosal damage? Its effect on acid and gastrin physiology. Gastroenterology 113 (6 Suppl.):S43-9.
15. Leban, J. J., Kull, F. C., Jr., Landavazo, A., Stockstill, B. and McDermed, J. D. (1993) Development of potent gastrin-releasing peptide antagonists having a D-Pro-psi(CH2NH)-Phe-NH2 C terminus. Proc. Natl. Acad. Sci. USA 90, 1922-1926.
16. Buck, I. M., Black, J. W., Cooke, T., Dunstone, D. J., Gaffen, J. D., Griffin, E. P., Harper, E. A., Hull, R. A., Kalindjian, S. B., Lilley, E. J., Linney, I. D., Low, C. M., McDonald, I. M., Pether, M. J., Roberts, S. P., Shankley, N. P., Shaxted, M. E., Steel, K. I., Sykes, D. A., Tozer, M. J., Watt, G. F., Walker, M. K., Wright, L. and Wright, P. T. (2005) Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists. J. Med. Chem. 48, 6803-6812.
17. Prinz, C., Zanner, R. and Gratzl, M. (2003) Physiology of gastric enterochromaffin-like cells. Annu. Rev. Physiol. 65, 371-382.
18. Fellenius, E., Berglindh, T., Sachs, G., Olbe, L., Elander, B., Sjostrand, S. E. and Wallmark, B. (1981) Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase. Nature 290, 159-161.
19. Wallmark, B., Sachs, G., Mardh, S. and Fellenius, E. (1983) Inhibition of gastric (H+ + K+)-ATPase by the substituted benzimidazole, picoprazole. Biochim. Biophys. Acta 728, 31-38.
20. Shin, J. M. and Sachs, G. (2002) Restoration of acid secretion following treatment with proton pump inhibitors. Gastroenterology 123, 1588-1597.
21. Kaminski, J. J., Bristol, J. A., Puchalski, C., Lovey, R. G., Elliott, A. J., Guzik, H., Solomon, D. M., Conn, D. J., Domalski, M. S., Wong, S. C., Gold, E. J., Long, J. F., Chiu, P. J. S., Steinberg, M. and McPhail, A. T. (1985) Antiulcer agents. 1. Gastric antisecretory and cytoprotective properties of substituted imidazo[1,2-a]pyridines. J. Med. Chem. 28, 876-892.
22. Wallmark, B., Briving, C., Fryklund, J., Munson, K., Jackson, R., Mendlein, J., Rabon, E. and Sachs, G. (1987) Inhibition of gastric H+,K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole. J. Biol. Chem. 262, 2077-2084.
23. Shull, G. E. and Lingrel, J. B. (1986) Molecular cloning of the rat stomach (H+ + K+)-ATPase. J. Biol. Chem. 261, 16788-16791.
24. Maeda, M., Ishizaki, J. and Futai, M. (1988) cDNA cloning and sequence determination of pig gastric (H+ + K+)-ATPase. Biochem. Biophys. Res. Commun. 157, 203-209.
25. Bamberg, K., Mercier, F., Reuben, M. A., Kobayashi, Y., Munson, K. B. and Sachs, G. (1992) cDNA cloning and membrane topology of the rabbit gastric H+/K(+)-ATPase alpha-subunit. Biochim. Biophys. Acta 1131, 69-77.
26. Maeda, M., Oshiman, K., Tamura, S. and Futai, M. (1990) Humangastric (H+ + K+)-ATPase gene. Similarity to (Na+ + K+)-ATPase genes in exon/intron organization but difference in control region. J. Biol. Chem. 265, 9027-9032.
27. Munson, K., Garcia, R. and Sachs, G. (2005) Inhibitor and ion binding sites on the gastric H,K-ATPase. Biochemistry 44, 5267-5284.
28. Rabon, E. C., McFall, T. L. and Sachs, G. (1982) The gastric [H,K]ATPase:H+/ATP stoichiometry. J. Biol. Chem. 257, 6296-6299.
29. Sweadner, K. J. and Donnet, C. (2001) Structural similarities of Na,K-ATPase and SERCA, the Ca(2+)-ATPase of the sarcoplasmic reticulum. Biochem. J. 356, 685-704.
30. Post, R. L. (1989) Seeds of sodium, potassium ATPase. Annu Rev Physiol 51, 1-15.
31. Abe, K., Kaya, S., Hayashi, Y., Imagawa, T., Kikumoto, M., Oiwa, K., Katoh, T., Yazawa, M. and Taniguchi, K. (2003) Correlation between the activities and the oligomeric forms of pig gastric H/K-ATPase. Biochemistry 42, 15132-15138.
32. Shin, J. M., Grundler, G., Senn-Bilfinger, J., Simon, W. A. and Sachs, G. (2005) Functional Consequences of the Oligomeric Form of the Membrane-Bound Gastric H,K-ATPase. Biochemistry 44, 16321-16332.
33. Taniguchi, K., Kaya, S., Abe, K. and Mardh, S. (2001) The oligomeric nature of Na/K-transport ATPase. J. Biochem. (Tokyo) 129, 335-342.
34. Bamberg, K. and Sachs, G. (1994) Topological analysis of H+,K(+)-ATPase using in vitro translation. J. Biol. Chem. 269, 16909-16919, 1994).
35. Vagin, O., Denevich, S., Munson, K. and Sachs, G. (2002) SCH28080, a K+-competitive inhibitor of the gastric H,K-ATPase, binds near the M5-6 luminal loop, preventing K+ access to the ion binding domain. Biochemistry 41, 12755-12762.
36. Jorgensen, P. L., Hakansson, K. O. and Karlish, S. J. (2003) Structure and mechanism of Na,K-ATPase: functional sites and their interactions. Annu. Rev. Physiol. 65, 817-849.
37. Blostein, R., Dunbar, L., Mense, M., Scanzano, R., Wilczynska, A. and Caplan, M. J. (1999) Cation selectivity of gastric H,K-ATPase and Na,K-ATPase chimeras. J. Biol. Chem. 274, 18374-18381.
38. McIntosh, D. B., Clausen, J. D., Woolley, D. G., MacLennan, D. H., Vilsen, B. and Andersen, J. P. (2004) Roles of conserved P domain residues and Mg2+ in ATP binding in the ground and Ca2+-activated states of sarcoplasmic reticulum Ca2+-ATPase. J. Biol. Chem. 279, 32515-32523.
39. De Pont, J. J., Swarts, H. G., Willems, P. H. and Koenderink, J. B. (2003) The E1/E2-preference of gastric H,K-ATPase mutants. Ann. NY Acad. Sci. 986, 175-182.
40. Reuben, M. A., Lasater, L. S. and Sachs, G. (1990) Characterization of a beta subunit of the gastric H+/K(+)-transporting ATPase. Proc. Natl. Acad. Sci. USA 87, 6767-6771.
41. Shull, G. E. (1990) cDNA cloning of the beta-subunit of the rat gastric H,K-ATPase. J. Biol. Chem. 265, 12123-12126.
42. Toh, B. H., Gleeson, P. A., Simpson, R. J., Moritz, R. L., Callaghan, J. M., Goldkorn, I., Jones, C. M., Martinelli, T. M., Mu, F. T., Humphris, D. C., Pettit, J. M. Mori, Y., Masuda, T., Sobeiszczuk P., Weinstock, J., Mantamadiotis, T. and Baldwin, G. (1990) The 60- to 90-kDa parietal cell autoantigen associated with autoimmune gastritis is a beta subunit of the gastric H+/K(+)-ATPase (proton pump). Proc. Natl. Acad. Sci. USA 87, 6418-6422.
43. Blanco, G. and Mercer, R. W. (1998) Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am. J. Physiol. 275, F633-650.
44. Toyoshima, C., Asahi, M., Sugita, Y., Khanna, R., Tsuda, T. and MacLennan, D. H. (2003) Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase. Proc. Natl. Acad. Sci. USA 100, 467-472.
45. Toyoshima, C., Nakasako, M., Nomura, H. and Ogawa, H. (2000) Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 A resolution. Nature 405, 647-655.
46. Toyoshima, C., Nomura, H. and Sugita, Y. (2003) Crystal structures of Ca2+-ATPase in various physiological states. Ann. NY Acad. Sci. 986, 1-8.
47. Melle-Milovanovic, D., Milovanovic, M., Nagpal, S., Sachs, G. and Shin, J. M. (1998) Regions of association between the alpha and the beta subunit of the gastric H,K-ATPase. J. Biol. Chem. 273, 11075-11081.
48. Shin, J. M. and Sachs, G. (1994) Identification of a region of the H,K-ATPase alpha subunit associated with the beta subunit. J. Biol. Chem. 269, 8642-8646.
49. Hebert, H., Purhonen, P., Vorum, H., Thomsen, K. and Maunsbach, A. B. (2001) Three-dimensional structure of renal Na,K-ATPase from cryo-electron microscopy of two-dimensional crystals. J. Mol. Biol. 314, 479-494.
50. Munson, K., Vagin, O., Sachs, G. and Karlish, S. (2003) Molecular modeling of SCH28080 binding to the gastric H,K-ATPase and MgATP interactions with SERCA- and Na,K-ATPases. Ann. NYAcad. Sci. 986, 106-110.
51. Shin, J. M., Cho, Y. M. and Sachs, G. (2004) Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors. J. Am. Chem. Soc. 126, 7800-7811.
52. Shin, J. M., Homerin, H., Domagala, F., Ficheux, H. and Sachs, G. (2006) Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+-ATPase in vitro and in vivo. Biochem. Pharmacol. 71, 837-849.
53. Besancon, M., Shin, J. M., Mercier, F., Munson, K., Miller, M., Hersey, S. and Sachs, G. (1993) Membrane topology and omeprazole labeling of the gastric H+,K(+)- adenosinetriphosphatase. Biochemistry 32, 2345-2355.
54. Sachs, G., Shin, J. M., Besancon, M. and Prinz, C. (1993) The continuing development of gastric acid pump inhibitors. Aliment Pharmacol. Ther. 7, 4-12.
55. Shin, J. M., Besancon, M., Simon, A. and Sachs, G. (1993) The site of action of pantoprazole in the gastric H+/K(+)-ATPase. Biochim. Biophys. Acta 1148, 223-233.
56. Shin, J. M. and Sachs, G. (2004) Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo. Biochem. Pharmacol. 68, 2117-2127.
57. Gedda, K., Scott, D., Besancon, M., Lorentzon, P. and Sachs, G. (1995) Turnover of the gastric H+,K(+)-adenosine triphosphatase alpha subunit and its effect on inhibition of rat gastric acid secretion. Gastroenterology 109, 1134-1141.
58. Im, W. B., Blakeman, D. P. and Davis, J. P. (1985) Irreversible inactivation of rat gastric (H+-K+)-ATPase in vivo by omeprazole. Biochem. Biophys. Res. Commun. 126, 78-82.
59. Wallmark, B., Larsson, H. and Humble, L. (1985) The relationship between gastric acid secretion and gastric H+,K+- ATPase activity. J. Biol. Chem. 260, 13681-13684.
60. Dammann, H. G. and Burkhardt, F. (1999) Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion. Eur. J. Gastroenterol. Hepatol. 11, 1277-1282.
61. Katashima, M., Yamamoto, K., Tokuma, Y., Hata, T., Sawada, Y. and Iga, T. (1998) Comparative pharmacokinetic/pharmacodynamic analysis of proton pump inhibitors omeprazole, lansoprazole and pantoprazole, in humans. Eur. J. Drug Metab. Pharmacokinet. 23, 19-26.
62. Yuan, Y., Padol, I. T. and Hunt, R. H. (2006) Peptic ulcer disease today. Nat. Clin. Pract. Gastroenterol. 3: 80-89.
63. Huang, J. Q., Sridhar, S. and Hunt, R. H. (2002) Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 359, 14-22.
64. Suerbaum, S. and Michetti, P. (2002) Helicobacter pylori infection. N. Engl. J. Med. 347, 1175-1186.
65. Delaney, B., Moayyedi, P. and Forman, D. (2006) Helicobacter pylori infection. Clin. Evid. 15, 1-2.
66. Hung, L. C., Ching, J. Y., Sung, J. J., To, K. F., Hui ,A. J., Wong, V. W., Leong, R. W., Chan, H. L., Wu, J. C., Leung, W. K., Lee, Y. T., Chung, S. C. and Chan, F. K. (2005). Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. Gastroenterology 128, 1845-1850.
67. Moayyedi, P. and Talley, N. J. (2006) Gastro-oesophageal reflux disease. Lancet 367, 2086-2100.
68. Shaheen, N. J., Hansen, R. A., Morgan, D. R., Gangarosa, L. M., Ringel, Y., Thiny, M. T., Russo, M. W. and Sandler, R. S. (2006). The burden of gastrointestinal and liver diseases, 2006. Am. J. Gastroenterol. 101, 2128-2138.
69. Dallemagne, B., Weerts, J. M., Jehaes, C., Markiewicz, S. and Lombard. R. (1991). Laparoscopic Nissen fundoplication: preliminary report. Surg. Laparosc. Endosc. 1, 138-143.
70. Vakil, N., Shaw, M. and Kirby, R. (2003). Clinical effectiveness of laparoscopic fundoplication in a U.S. community. Am. J. Med. 114, 1-5.
71. Vaezi, M. F. (2004) 'Refractory GERD': acid, nonacid, or not GERD? Am. J. Gastroenterol. 99, 989-991.
72. Vakil, N., van Zanten, S. V., Kahrilas, P., Dent, J. and Jones, R. (2006). Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am. J. Gastroenterol. 101, 1900-1920.
73. Quigley, E. M. (2004) Functional dyspepsia (FD) and nonerosive reflux disease (NERD): overlapping or discrete entities? Best Pract. Res. Clin. Gastroenterol.18, 695-706.
74. Stanghellini, V., Armstrong, D., Monnikes, H. and Bardhan, K. D. (2004) Systematic review: do we need a new gastrooesophageal reflux disease questionnaire? Aliment. Pharmacol. Ther. 19, 463-479.
75. Armstrong, D., Monnikes, H., Bardhan, K. D. and Stanghellini, V. (2004). The construction of a new evaluative GERD questionnaire - methods and state of the art. Digestion 70, 71-78.
76. Bardhan, K. D., Achim, A., Riddermann, T. and Pfaffenberger, B. (2007). A clinical trial comparing pantoprazole and esomeprazole to explore the concept of achieving 'complete remission' in gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 25, 1461-1469.
77. Barkun, A., Bardou, M. and Marshall, J. K. (2003). Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann. Intern. Med. 139:843-857.
78. Cash, B. D. (2002). Evidence-based medicine as it applies to acid suppression in the hospitalized patient. Crit. Care Med. 30(6 suppl.), S373-378.
79. Levine, J. E., Leontiadis, G. I., Sharma, V. K. and Howden, C. W. (2002) Meta-analysis: the efficacy of intravenous H2-receptor antagonists in bleeding peptic ulcer. Aliment. Pharmacol. Ther.16, 1137-1142.
80. Zed, P. .J., Loewen, P. S., Slavik, R. S. and Marra, C. A. (2001). Meta-analysis of proton pump inhibitors in treatment of bleeding peptic ulcers. Ann. Pharmacother.35, 1528-1534.
81. Cook, D. J., Reeve, B. K., Guyatt, G. H., Heyland, D. K., Griffith, L. E., Buckingham, L. and Tryba, M. (1996) Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA 275, 308-314.
82. Kromer, W., Postius, S. and Riedel, R. (2000) Animal pharmacology of reversible antagonism of the gastric acid pump, compared to standard antisecretory principles. Pharmacology 60, 179-187.
83. Larsson, H., Carlsson, E., Junggren, U., Olbe, L., Sjostrand, S. E., Skanberg, I. and Sundell, G. (1983) Inhibition of gastric acid secretion by omeprazole in the dog and rat. Gastroenterology 85, 900-917.
84. Huggins, R. M., Scates, A. C. and Latour, J. K. (2003) Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding. Ann. Pharmacother. 37, 433-437.
85. Lanas, A., Artal, A., Blas, J. M., Arroyo, M. T., Lopez-Zaborras, J. and Sainz, R. (1995) Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer. J. Clin. Gastroenterol. 21, 103-106.
86. Smith, J. and Karlstadt, R. (2003) Rapid gastric pH improvement from NPO to enteral-fed period with intermittent intravenous (IV) pantoprazole (P) vs. continually infused cimetidine (C). Am. J. Gastroenterol. 98, S41.
87. Hunt, R. H., Armstrong, D., James, C., Chowdhury, S. K., Yuan, Y., Fiorentini, P., Taccoen, A. and Cohen, P. (2005) Effect on intragastricpHof a PPI with a prolonged plasma half-life: comparison between tenatoprazole and esomeprazole on the duration of acid suppression in healthy male volunteers. Am. J. Gastroenterol. 100, 1949-1956.
88. Hunt, R. H., Armstrong, D., Yaghoobi, M., James, C., Chen, Y., Leonard, J., Shin, J. M. and Sachs, G. (2006). AGN 201904Z (AGN), a novel enteric-coated PPI, produces greater, more prolonged acid suprression than esomeprazole (ESO) in male healthy volunteers. Am. J. Gastroenterol. 101 (suppl.), S 92.
89. Munson, K., Law, R. J. and Sachs, G. (2007) Analysis of the gastric H,K ATPase for ion pathways and inhibitor binding sites. Biochemistry 46, 5398-5417.